Editorial: Feasibility of aerosolized colistin in the era of escalating drug-resistant Pseudomonas pneumonia: Pressing need for validation clinical trials

Intensive Care Medicine

Volumn 36, Issue 7, 2010, Pages 1110-1111

  Safdar, Amar ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; ANTIINFECTIVE AGENT;

AEROSOL; ANTIMICROBIAL ACTIVITY; AREA UNDER THE CURVE; BACTERIAL COLONIZATION; BACTERIAL PNEUMONIA; BRONCHUS; DISEASE SEVERITY; DRUG BIOAVAILABILITY; DRUG EFFICACY; EDITORIAL; FEASIBILITY STUDY; LONG TERM CARE; LUNG BURDEN; NONHUMAN; PSEUDOMONAS INFECTION; ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; HUMAN; INHALATIONAL DRUG ADMINISTRATION; NOTE;

ADMINISTRATION, INHALATION; ANTI-BACTERIAL AGENTS; CLINICAL TRIALS AS TOPIC; COLISTIN; DRUG RESISTANCE, BACTERIAL; HUMANS; PNEUMONIA, BACTERIAL; PSEUDOMONAS INFECTIONS;

EID: 77954385144     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-010-1883-8     Document Type: Editorial

References (12)

1. A Torres S Ewig H Lode J Carlet European HAP working group 2009 Defining, treating and preventing hospital acquired pneumonia: European perspective Intensive Care Med 35 9 29 10.1007/s00134-008-1336-9 18989656
2. E Wolinsky JD Hines 1962 Neurotoxic and nephrotoxic effects of colistin patients with renal disease N Engl J Med 266 759 762 1:STN:280: DyaF387pvF2rsw%3D%3D 14008070
3. BK Rubin 2008 Aerosolized antibiotics for non-cystic fibrosis bronchiectasis J Aerosol Med Pulm Drug Deliv 21 71 76 10.1089/jamp.2007.0652 1:CAS:528:DC%2BD1cXjvFehsr8%3D 18518833
4. JL Burns JM Van Dalfsen RM Shawar KL Otto RL Garber JM Quan AB Montgomery GM Albers BW Ramsey AL Smith 1999 Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis J Infect Dis 179 1190 1196 10.1086/314727 1:CAS:528:DyaK1MXjtFKgtLk%3D 10191222
5. ME Falagas II Siempos IA Bliziotis A Michalopoulos 2006 Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials Crit Care 10 R123 10.1186/cc5032 16934148
6. ME Falagas PI Rafailidis E Ioannidou VG Alexiou DK Matthaiou DE Karageorgopoulos A Kapaskelis D Nikita A Michalopoulos 2010 Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients Int J Antimicrob Agents 35 194 199 10.1016/j.ijantimicag.2009.10.005 1:CAS:528:DC%2BD1MXhs1WltbvL 20006471
7. DE Ghannam GH Rodriguez II Raad A Safdar 2009 Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance Eur J Clin Microbiol Infect Dis 28 253 259 10.1007/s10096-008-0620-5 1:CAS:528: DC%2BD1MXitlGgu7c%3D 18752007
8. N Aoki K Tateda Y Kikuchi S Kimura C Miyazaki Y Ishii Y Tanabe F Gejyo K Yamaguchi 2009 Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa J Antimicrob Chemother 63 534 542 10.1093/jac/dkn530 1:CAS:528:DC%2BD1MXitVSitLw%3D 19147523
9. GS Bauldoff DR Nunley JD Manzetti JH Dauber RJ Keenan 1997 Use of aerosolized colistin sodium in cystic fibrosis patients awaiting lung transplantation Transplantation 64 748 752 10.1097/00007890-199709150-00015 1:CAS:528:DyaK2sXms12nsrg%3D 9311714
10. A Safdar SA Shelburne SE Evans BF Dickey 2009 Inhaled therapeutics for prevention and treatment of pneumonia Expert Opin Drug Saf 8 435 449 10.1517/14740330903036083 1:CAS:528:DC%2BD1MXns1Cgs7g%3D 19538104
11. Lu Q, Girardi C, Zhang M, Bouhemad B, Louchahi K, Petitjean O, Wallet F, Becquemin MH, Ingeneer GN, Marquette CH, Rouby JJ (2010) Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa. Intensive Care Med. doi: 10.1007/s00134-010-1879-4
12. I Goldstein F Wallet A Nicolas-Robin F Ferrari CH Marquette JJ Rouby 2002 Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets Am J Respir Crit Care Med 66 1375 1381 10.1164/rccm.200204-363OC